Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial.

MLA

Witzens-Harig, Mathias, et al. “Rituximab Maintenance Improves Survival in Male Patients with Diffuse Large B-Cell Lymphoma. Results of the HD2002 Prospective Multicentre Randomized Phase III Trial.” British Journal of Haematology, vol. 171, no. 5, Dec. 2015, pp. 710–19. EBSCOhost, https://doi.org/10.1111/bjh.13652.

APA

Witzens-Harig, M., Benner, A., McClanahan, F., Klemmer, J., Brandt, J., Brants, E., Rieger, M., Meissner, J., Hensel, M., Neben, K., Dreger, P., Lengfelder, E., Schmidt-Wolf, I., Krämer, A., & Ho, A. D. (2015). Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial. British Journal of Haematology, 171(5), 710–719. https://doi.org/10.1111/bjh.13652

Chicago

Witzens-Harig, Mathias, Axel Benner, Fabienne McClanahan, Jennifer Klemmer, Julia Brandt, Elke Brants, Michael Rieger, et al. 2015. “Rituximab Maintenance Improves Survival in Male Patients with Diffuse Large B-Cell Lymphoma. Results of the HD2002 Prospective Multicentre Randomized Phase III Trial.” British Journal of Haematology 171 (5): 710–19. doi:10.1111/bjh.13652.